Electromed, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDElectromed, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 91), indicating clear outperformance against the broad market. Earnings growth of 67% provides fundamental context to the price action. Investors should exercise caution due to high volatility (53% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $37.48 | +2.46% | ABOVE |
| 50 SMA | $32.02 | +19.94% | ABOVE |
| 100 SMA | $28.53 | +34.58% | ABOVE |
| 150 SMA | $28.32 | +35.57% | ABOVE |
| 200 SMA | $27.39 | +40.21% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ELMD in an uptrend right now?
ELMD has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, ELMD is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is ELMD overbought or oversold?
ELMD's RSI (14) is 65. The stock is in neutral territory, neither overbought nor oversold.
Is ELMD outperforming the market?
ELMD has a Relative Strength (RS) Rating of 91 out of 99. Yes, ELMD is a market leader, outperforming 91% of all stocks over the past 12 months.
Where is ELMD in its 52-week range?
ELMD is trading at $38.40, which is 97% of its 52-week high ($39.65) and 94% above its 52-week low ($17.73).
How volatile is ELMD?
ELMD has a Beta of 0.92 and 52-week volatility of 53%. It's less volatile than the S&P 500 - generally more stable.